2-aminomethyl-4-t-butyl-6-iodophenol has been researched along with angiotensin ii in 2 studies
| Studies (2-aminomethyl-4-t-butyl-6-iodophenol) | Trials (2-aminomethyl-4-t-butyl-6-iodophenol) | Recent Studies (post-2010) (2-aminomethyl-4-t-butyl-6-iodophenol) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
|---|---|---|---|---|---|
| 41 | 0 | 1 | 38,152 | 1,089 | 7,413 |
| Protein | Taxonomy | 2-aminomethyl-4-t-butyl-6-iodophenol (IC50) | angiotensin ii (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, Y; Katori, M; Kawamura, M | 1 |
| Bell-Quilley, CP; Drugge, ED; Hilchey, SD; Lin, YS; McGiff, JC | 1 |
2 other study(ies) available for 2-aminomethyl-4-t-butyl-6-iodophenol and angiotensin ii
| Article | Year |
|---|---|
Enhancement of endogenous prostaglandin I2 (prostacyclin) generation in vivo by a phenolic anti-inflammatory agent in the rabbit.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Butylated Hydroxytoluene; Epoprostenol; Indomethacin; Male; Rabbits; Thromboxane B2 | 1991 |
Renovascular actions of angiotensin II in the isolated kidney of the rat: relationship to lipoxygenases.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Angiotensin II; Animals; Butylated Hydroxytoluene; Cyclooxygenase Inhibitors; Filtration; Flavanones; Flavonoids; Glomerular Filtration Rate; In Vitro Techniques; Indomethacin; Kidney; Lipoxygenase; Lipoxygenase Inhibitors; Male; Perfusion; Prostaglandin Endoperoxides, Synthetic; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Vascular Resistance | 1993 |